Identification of p38 beta as a therapeutic target for the treatment of Sézary Syndrome

Cutaneous T-Cell Lymphomas (CTCL) represent a group of hematopoietic malignancies that home to the skin and have no known molecular basis for disease pathogenesis. Sézary syndrome (SS) is the leukemic variant of CTCL. Currently, CTCL is incurable, highlighting the need for new therapeutic modalities...

Descripción completa

Detalles Bibliográficos
Autores principales: Bliss-Moreau, Meghan, Coarfa, Cristian, Gunaratne, Preethi H, Guitart, Joan, Krett, Nancy L, Rosen, Steven T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4289446/
https://www.ncbi.nlm.nih.gov/pubmed/25148579
http://dx.doi.org/10.1038/jid.2014.367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4289446/
https://www.ncbi.nlm.nih.gov/pubmed/25148579
http://dx.doi.org/10.1038/jid.2014.367

Ejemplares similares